FDA issued a Warning Letter to Horizon Pharmaceuticals, Inc. on 12/23/2016 for a previous inspection.
483 Horizon Pharmaceuticals Aug 2018

483 Horizon Pharmaceuticals Aug 2018

Jennifer Lalama FDA, Shavon Square FDA$119.00 - Available Now

FDA investigators audited the Horizon Pharmaceuticals - Riviera Beach, FL, United States facility and issued inspectional observations (via FDA 483) on 17 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Aug 2018
  • Location: Riviera Beach, United States
  • FEI: 3000718824
Add To Cart